# ACS Dobfar S.p.A. – FDA Inspection, Jul 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/584779c1-9978-4f42-ac8d-32841973f716
Source feed: FDA_Inspections

> FDA inspection 1019162 of ACS Dobfar S.p.A., July 21, 2017. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1019162
- Company Name: ACS Dobfar S.p.A.
- Inspection Date: 2017-07-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- FDA Inspection 1203381 - 2022-04-08
- FDA Inspection 1123735 - 2018-04-13
- [FDA Inspection 955350 - 2016-01-19](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/26802884-ae0f-4afa-94bd-6b134f9c3430)
- FDA Inspection 881223 - 2014-05-23
- [FDA Inspection 777346 - 2012-03-27](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/f9cc5678-8659-48f5-96b4-e42dc711e3ad)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/alan-p-kurtzberg/36ee316e-6d19-44b2-a131-fc254ada4f41)
- [FDA Associated Person](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)

Company: https://www.keypedia.com/companies/acs-dobfar-spa/8d824293-8979-42d8-822b-2373460bbf88

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c